Dissolution from solid lipid extrudates containing release modifiers

Area of Science:

• Pharmaceutical Technology
• Drug Delivery Systems
• Materials Science

Background:

• Solid lipid extrudates are a promising drug delivery system.
• Controlling drug release from lipid matrices is crucial for therapeutic efficacy.
• Release modifiers can alter the physicochemical properties of extrudates.

Purpose of the Study:

• To investigate the impact of different release modifiers on diprophylline dissolution from solid lipid extrudates.
• To compare the efficacy of hydrocolloids, disintegrants, and pore formers in modulating drug release.
• To explore the influence of polyethylene glycol (PEG) as a pore former at extrusion temperatures.

Main Methods:

• Solid lipid extrusion of diprophylline with tristearin and various release modifiers.
• Characterization of extrudates and assessment of diprophylline dissolution profiles.
• Comparative analysis of drug release rates with different modifier types and concentrations.
• Investigation of polyethylene glycol (PEG) behavior at extrusion temperatures (65°C).

Main Results:

• All release modifier-containing extrudates demonstrated faster diprophylline release than the reference (50% API/50% lipid).
• Increasing diprophylline content to 55% improved release, but not all modifiers further enhanced this.
• Among pore formers, polyethylene glycol (PEG) significantly increased release rates compared to sodium chloride or mannitol.
• The enhanced release with PEG was linked to its molten state during the 65°C extrusion process.

Conclusions:

• Release modifiers, particularly pore formers like PEG, can effectively enhance drug dissolution from solid lipid extrudates.
• The choice of release modifier and processing conditions (e.g., extrusion temperature) are critical for optimizing drug release profiles.
• Polyethylene glycol (PEG) presents a viable option for developing rapidly dissolving solid lipid extrudates when processed at appropriate temperatures.